| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |